233 related articles for article (PubMed ID: 7957111)
1. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
Bouvard V; Storey A; Pim D; Banks L
EMBO J; 1994 Nov; 13(22):5451-9. PubMed ID: 7957111
[TBL] [Abstract][Full Text] [Related]
2. Epithelial specific transcriptional regulation of the bovine papillomavirus 4 promoter by E2.
Morgan IM; Grindlay GJ; Campo MS
J Gen Virol; 1998 Mar; 79 ( Pt 3)():501-8. PubMed ID: 9519828
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
Hou SY; Wu SY; Chiang CM
J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
[TBL] [Abstract][Full Text] [Related]
4. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
5. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
Vance KW; Campo MS; Morgan IM
J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
[TBL] [Abstract][Full Text] [Related]
6. Importance of the bovine papillomavirus P2443 promoter in the regulation of E2 and E5 expression.
Spalholz BA
J Virol; 1993 Oct; 67(10):6278-84. PubMed ID: 8396681
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7.
Nasseri M; Gage JR; Lorincz A; Wettstein FO
Virology; 1991 Sep; 184(1):131-40. PubMed ID: 1651587
[TBL] [Abstract][Full Text] [Related]
8. Suppression of cellular proliferation by the papillomavirus E2 protein.
Dowhanick JJ; McBride AA; Howley PM
J Virol; 1995 Dec; 69(12):7791-9. PubMed ID: 7494290
[TBL] [Abstract][Full Text] [Related]
9. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.
Kovelman R; Bilter GK; Glezer E; Tsou AY; Barbosa MS
J Virol; 1996 Nov; 70(11):7549-60. PubMed ID: 8892874
[TBL] [Abstract][Full Text] [Related]
14. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
16. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.
Stubenrauch F; Hummel M; Iftner T; Laimins LA
J Virol; 2000 Feb; 74(3):1178-86. PubMed ID: 10627528
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
18. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.
McBride AA; Byrne JC; Howley PM
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):510-4. PubMed ID: 2536165
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
20. Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.
Haugen TH; Turek LP; Mercurio FM; Cripe TP; Olson BJ; Anderson RD; Seidl D; Karin M; Schiller J
EMBO J; 1988 Dec; 7(13):4245-53. PubMed ID: 2854060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
